Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Terbutaline Pump Maintenance Therapy After Threatened Preterm Labour for Reducing Adverse Neonatal Outcomes." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435742/all/Terbutaline_pump_maintenance_therapy_after_threatened_preterm_labour_for_reducing_adverse_neonatal_outcomes.
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435742/all/Terbutaline_pump_maintenance_therapy_after_threatened_preterm_labour_for_reducing_adverse_neonatal_outcomes. Accessed February 10, 2025.
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435742/all/Terbutaline_pump_maintenance_therapy_after_threatened_preterm_labour_for_reducing_adverse_neonatal_outcomes
Terbutaline Pump Maintenance Therapy After Threatened Preterm Labour for Reducing Adverse Neonatal Outcomes [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435742/all/Terbutaline_pump_maintenance_therapy_after_threatened_preterm_labour_for_reducing_adverse_neonatal_outcomes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes
ID - 435742
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435742/all/Terbutaline_pump_maintenance_therapy_after_threatened_preterm_labour_for_reducing_adverse_neonatal_outcomes
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -